Page last updated: 2024-11-12

altinicline maleate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

altinicline maleate: binds to neuronal nicotinic acetylcholine receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11954277
SCHEMBL ID15253516
MeSH IDM0578197

Synonyms (20)

Synonym
D02839
192231-16-6
altinicline maleate (usan)
altinicline maleate
5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate
unii-pcl7q9q62q
(s)-3-ethynyl-5-(1-methyl-2-pyrrolidinyl)pyridine (z)-2-butenedioate (1:1)
pcl7q9q62q ,
altinicline maleate [usan]
(-)-5-ethynylnicotine maleate (1:1)
pyridine, 3-ethynyl-5-((2s)-1-methyl-2-pyrrolidinyl)-, (2z)-2-butenedioate(1:1)
(-)-3-ethynyl-5-((s)-1-methyl-2-pyrrolidinyl)pyridine maleate (1:1)
AKOS024458337
sib 1508y maleate
SCHEMBL15253516
3-ethynyl-5-[(2s)-1-methyl-2-pyrrolidinyl]pyridine maleate salt
pyridine, 3-ethynyl-5-[(2s)-1-methyl-2-pyrrolidinyl]-, (2z)-2-butenedioate (1:1)
Q27286481
(z)-but-2-enedioate;3-ethynyl-5-[(2s)-1-methylpyrrolidin-1-ium-2-yl]pyridin-1-ium
(z)-but-2-enedioic acid;3-ethynyl-5-[(2s)-1-methylpyrrolidin-2-yl]pyridine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Lightheadedness was a common dosage-related adverse effect at higher dosages, leading to frequent dosage reduction, drug discontinuation, and eventual trial redesign."( Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease.
, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (43.75)18.2507
2000's8 (50.00)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.26 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.15 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (6.25%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]